RadioGraphics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/rg.272065058
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Test (opens in a new window)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scarsbrook, A. F.
Right arrow Articles by Phillips, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scarsbrook, A. F.
Right arrow Articles by Phillips, R. R.
Related Collections
Right arrow Gastrointestinal Radiology
Right arrow Nuclear Medicine
Right arrow Oncologic Imaging
RadioGraphics 2007;27:455-477
© RSNA, 2007


EDUCATION EXHIBIT

Anatomic and Functional Imaging of Metastatic Carcinoid Tumors1

Andrew F. Scarsbrook, FRCR, Arul Ganeshan, MRCP, Jane Statham, DCR, Rajesh V. Thakker, FRCP, Andrew Weaver, FRCR, Denis Talbot, FRCP, Philip Boardman, FRCR, Kevin M. Bradley, FRCR, Fergus V. Gleeson, FRCR and Rachel R. Phillips, FRCR

1 From the Departments of Radiology (A.F.S., A.G., P.B., F.V.G., R.R.P.), Nuclear Medicine (A.F.S., J.S., K.M.B., F.V.G.), and Clinical Oncology (A.W.), Churchill Hospital, Oxford Radcliffe Hospitals NHS Trust, Headington, Oxford, England; Academic Endocrine Unit, Nuffield Department of Clinical Medicine, Oxford, England (R.V.T.); and Cancer Research UK, University of Oxford, Oxford, England (D.T.). Recipient of a Certificate of Merit award for an education exhibit at the 2005 RSNA Annual Meeting. Received April 6, 2006; revision requested June 29 and received August 21; accepted August 22. All authors have no financial relationships to disclose. Address correspondence to A.F.S., Department of Clinical Radiology, St James’s University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett St, Leeds, LS9 7TF, England (e-mail: andrew.scarsbrook{at}leedsth.nhs.uk).

Carcinoid tumors are a fascinating group of neuroendocrine neoplasms that develop either sporadically or as part of an inheritable syndrome. Many tumors arise in the bronchopulmonary or gastrointestinal tract, but a neuroendocrine tumor can arise in almost any organ. The tumors have varied malignant potential depending on the site of their origin, and the clinical manifestations often are nonspecific. Metastases may be present at the time of diagnosis, which often occurs at a late stage of the disease. Imaging plays a pivotal role in the localization and staging of neuroendocrine tumors and in monitoring the treatment response. Imaging is often challenging, and a combination of anatomic and functional techniques is usually required, depending on the tumor type and location. Techniques include ultrasonography, barium studies, endoscopy, computed tomography, magnetic resonance imaging, somatostatin receptor scintigraphy, iobenguane scintigraphy, and, in select cases, positron emission tomography. Coregistration of structural and functional images is often of incremental value for accurate localization of the primary tumor and any meta-static disease. Radiologists must understand the contribution of each imaging modality in the assessment of different neuroendocrine tumors. In addition, knowledge of the optimal technique for each radiologic and radionuclide imaging examination is essential. Familiarity with the protean imaging appearances of both primary and metastatic disease is essential for accurate staging, treatment monitoring, and surveillance. Finally, an understanding of the wide variety of treatment options for patients with carcinoid tumors is vital for optimal management.

© RSNA, 2007




This article has been cited by other articles:


Home page
JNMHome page
D. A. Mankoff, J. M. Link, H. M. Linden, L. Sundararajan, and K. A. Krohn
Tumor Receptor Imaging
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 149S - 163S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOGRAPHICS RADIOLOGY RSNA JOURNALS ONLINE
Copyright © 2007 by the Radiological Society of North America.